Gene: TRABD2B
Official Full Name: TraB domain containing 2Bprovided by HGNC
Gene Summary: Enables Wnt-protein binding activity and metalloendopeptidase activity. Involved in several processes, including negative regulation of Wnt signaling pathway; positive regulation of protein oxidation; and positive regulation of protein-containing complex assembly. Located in organelle membrane and plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13086 | TRABD2B Knockout cell line (HeLa) | Human | TRABD2B | 1:3~1:6 | Negative | Online Inquiry |
KO13087 | TRABD2B Knockout cell line (HEK293) | Human | TRABD2B | 1:3~1:6 | Negative | Online Inquiry |
TRABD2B Gene Knockout Cell Lines are specially engineered cellular models that facilitate the in-depth study of the TRABD2B gene's role in biological processes. These knockout cell lines are generated through precise gene editing techniques, such as CRISPR/Cas9, leading to the complete removal or disruption of the TRABD2B gene. By eliminating this specific gene, researchers can elucidate its function, interactions, and implications in various cellular pathways, thus gaining valuable insights into health and disease mechanisms.
The key function of TRABD2B Gene Knockout Cell Lines lies in their ability to serve as a robust tool for dissecting gene function and assessing phenotypic changes resulting from the genetic alteration. These cell lines can reveal critical insights into gene interactions and network dynamics, providing a powerful means for investigating the contribution of TRABD2B in physiological and pathological contexts.
Scientifically, these cell lines are imperative for translational research, particularly in oncology and neurobiology, where aberrations in gene function can lead to disease. They represent a gold standard for drug discovery, enabling researchers to screen for therapeutic candidates that restore normal cellular functions disrupted by TRABD2B mutations or dysregulation.
Compared to traditional methods, our TRABD2B Gene Knockout Cell Lines offer a more targeted and efficient approach to studying gene functions. While conventional knockout models can be time-consuming and less reproducible, our lines are readily available, ensuring consistency and reliability in experimental outcomes.
For researchers and clinicians, these knockout cell lines are indispensable for enhancing the understanding of gene behavior in complex biological systems. They empower users with the capability to conduct high-quality research that can pave the way for innovative therapeutic strategies.
Our company prides itself on being at the forefront of gene editing technology, offering high-fidelity cellular models that meet rigorous scientific standards. We are committed to supporting researchers in their quest to uncover new biological insights, thereby driving forward the field of genetics and personalized medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.